Breast cancer is one of the most common cancers in women, with high rates of mortality and morbidity. According to a study, scientists have revealed a new function of ganoderic acids from Ganoderma lucidum (G. lucidum) for treating breast cancer. This is the first time scientists identified potential targets of ganoderic acids for breast cancer treatment using bioinformatics techniques. G. lucidum, also called as Lingzhi in Chinese, is a popular medicinal fungus. It has a unique therapeutic and pharmacological reputation in suppressing cancer/tumor progression, especially breast cancer, due to its embedded rich bioactive chemical constituents, mainly triterpenoids (ganoderic acids). In...